Recently new criteria for diagnosing vascular dementia (VaD) have been
suggested by (a) the State of California Alzheimer's Disease Diagnost
ic and Treatment Centres (ADDTC), and (b) the NINDS-AIREN group after
an international workshop convened by the National Institute for Neuro
logical Disorders and Stroke (NINDS), with support from the Associatio
n Internationale pour la Recherche et l'Enseignement en Neurosciences
(AIREN). We have retrospectively applied the new criteria to two group
s of patients who are thought by us to be suffering from VaD. The firs
t group (20 patients) had a raised Hachinski Ischaemic Score, i.e. 7 o
r more (mean HIS = 9.5), and a second group (20 patients) with an HIS
between 4 and 6 points (mean HIS = 4.9). In group 1, 19 patients fulfi
lled the ADDTC criteria for probable or possible VaD, compared with 16
patients who fulfilled the NINDS-AIREN criteria. In group 2, 11 patie
nts fulfilled the ADDTC criteria for probable or possible VaD, compare
d with only five patients who fulfilled the NINDS-AIREN criteria. This
suggests that the ADDTC criteria may be more sensitive than the NINDS
-AIREN criteria and the HIS. However, postmortem validation studies of
the new criteria are needed to determine if the improved sensitivity
of the ADDTC criteria is at the expense of their specificity.